Although not a mutation, almost all MDS, AML, and CML with inv(3)/t(3;3) have GATA2 haploinsufficiency due to the re-location of the GATA2 distal hematopoietic enhancer53,54. Here, GATA2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.